Tirzepatide (Mounjaro), a dual GLP-1/GIP receptor agonist, received UK approval for type 2 diabetes and is under evaluation for obesity treatment
Practical targets: 25 to 40 grams of protein at each meal
The amplitude (A) of spontaneous and Ca 2+ -induced swelling of the organelle suspension in a Ca 2+ -free medium and in the conditions of pore-formation activation with the action of PTP inducer of swelling of calcium ions was calculated as the difference in optical density values from 1 to 15 min mPTP-associated mitochondrial swelling was tested by the specific mPTP inhibitor cyclosporin A (CsA), which was added to the incubation medium in a concentration of 10 5 mol/L 5 min before the induction of pore formation
A California woman filed a lawsuit on April 6 in the Los Angeles County Superior Court, alleging that a plastic surgeon exposed her to excessive nitrous oxide during a liposuction procedure
Stop taking Saxenda immediately Sudden, severe joint pain with fever (temperature above 38C), which could indicate septic arthritis requiring emergency treatment Contact your GP promptly (same day) if you develop: First episode of sudden onset severe joint pain, redness, and swelling , to exclude septic arthritis and start appropriate treatment Recurrent gout attacks if you have a previous history Severe right-upper abdominal pain, fever or yellowing of skin/eyes , which could indicate gallbladder problems (a known risk with weight loss and GLP-1 medications) [1] Persistent nausea, vomiting, or diarrhoea that prevents adequate food or fluid intake Signs of dehydration , including dark urine, dizziness, or reduced urination Contact your GP within a few days if you experience: Symptoms of thyroid issues , such as a lump in the neck, persistent hoarseness, or difficulty swallowing Unexplained weight loss plateau or concerns about treatment effectiveness Routine follow-up should include: Regular monitoring appointments as recommended by your prescriber (typically every 3-6 months) Discussion of any new symptoms or concerns, however minor they may seem Review of weight loss progress and whether Saxenda remains appropriate Assessment of cardiovascular risk factors and overall metabolic health Medication review to identify potential drug interactions Remember that most patients tolerate Saxenda well , and serious side effects are uncommon
